Arkolith/Insider Trading/FHTX/Form 4

Gottschalk Adrian

Chief Executive Officer, DirectorFoghorn Therapeutics Inc. (FHTX) · full profile →Form 4 · filed Aug 18, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 17, 2023Gift(G)63K—$0512K
Aug 17, 2023Gift(G)63K—$00

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-23-006432) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML